Cytoprotective effect of tauroursodeoxycholate on hepatocyte apoptosis induced by peroxisome proliferator-activated receptor gamma ligand

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 7 PT2, 2008, Pages

  Nonaka, Michihiro ^a   Tazuma, Susumu ^a   Hyogo, Hideyuki ^a   Kanno, Keishi ^a   Chayama, Kazuaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Extracellular signal regulated kinase; Proliferator activated receptor gamma; Tauroursodeoxycholate; Troglitazone

Indexed keywords

BILE ACID; GLYCOCHENODEOXYCHOLIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STRESS ACTIVATED PROTEIN KINASE; TAUROURSODEOXYCHOLIC ACID; TROGLITAZONE;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CELL PROTECTION; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FETUS; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL;

EID: 47649104878     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.05073.x     Document Type: Article

References (36)

1. Mangelsdorf DJ, Thummel C, Beato M et al. The nuclear receptor superfamily: the second decade. Cell 1995 83 : 835 9.
2. Blanquart C, Barbier O, Fruchart JC, Staels B, Glineur C. Peroxisome proliferators-activated receptors: regulation of transcriptional activities and roles in inflammation. J. Steroid Biochem. Mol. Biol. 2003 85 : 273 5.
3. Koeffler, HP. Peroxisome proliferator-activated receptor and cancers. Clin. Cancer Res. 2003 9 : 1 9.
4. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1998 93 : 229 40.
5. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 1995 83 : 813 19.
6. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15Deoxy-Δ12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 1995 83 : 803 12.
7. Huang JT, Welch JS, Ricote M et al. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase. Nature 1999 400 : 378 82.
8. Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer SA. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other nonsteroidal anti-inflammatory drugs. J. Biol. Chem. 1997 272 : 3406 10.
9. Koga H, Sakisaka S, Harada M et al. Involvement of p21 (WAF1/Cip1), 27 (Kip1), and p18 (INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. Hepatology 2001 33 : 1087 97.
10. Han C, Demetris AJ, Michalopoulos GK, Zhan Q, Shelhamer JH, Wu T. PPAR gamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway. Hepatology 2003 38 : 167 77.
11. Rumi MA, Ishihara S, Kadowaki Y et al. Peroxisome proliferator-activated receptor gamma-dependent and -independent growth inhibition of gastrointestinal tumor cells. Genes Cells 2004 9 : 1113 23.
12. Motomura W, Tanno S, Takahashi N et al. Involvement of MEK-ERK signaling pathway in the inhibition of cell growth by troglitazone in human pancreatic cancer cells. Biochem. Biophys. Res. Commun. 2005 332 : 89 94.
13. Watkins PB, Whitcomb RW. Hepatic dysfunction associated with troglitazone. N. Engl. J. Med. 1998 26 : 916 17.
14. Scheen AJ. Thiazolidinediones and liver toxicity. Diabetes Metab. 2001 27 : 305 13.
15. Sagawa H, Tazuma S, Kajiyama G. Protection against hydrophobic bile salt-induced cell membrane damage by liposomes and hydrophilic bile salts. Am. J. Physiol. 1993 264 : G835 9.
16. Komichi D, Tazuma S, Nishioka T, Hyogo H, Une M, Chayama K. Unique inhibition of bile salt-induced apoptosis by lecithins and cytoprotective bile salts in immortalized mouse cholangiocytes. Dig. Dis. Sci. 2003 48 : 2315 22.
17. Takikawa Y, Miyoshi H, Rust C et al. The bile acid-activated phosphatidylinositol 3-kinase pathway inhibits Fas apoptosis upstream of bid in rodent hepatocytes. Gastroenterology 2001 120 : 1810 17.
18. Faubion WA, Guicciardi ME, Miyoshi H et al. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J. Clin. Invest. 1999 103 : 137 45.
19. Rust C, Kranitz LM, Paya CV, Moscat J, Simari RD, Gores GJ. The bile acid taurochenodeoxycholate activates a phosphatidylinostol 3-kinase-dependent survival signal cascade. J. Biol. Chem. 2000 275 : 20210 16.
20. Kobayashi N, Miyazaki M, Fukaya K et al. Transplantation of highly differentiated immortalized human hepatocytes to treat acute liver failure. Transplantation 2000 69 : 202 7.
21. Shishido S, Koga H, Harada M et al. Hydrogen peroxide overproduction in megamitochondria of troglitazone-treated human hepatocytes. Hepatology 2003 37 : 136 47.
22. Motomura W, Takahashi N, Nagamine M et al. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells. Int. J. Cancer 2004 108 : 41 6.
23. Toyoda M, Takagi H, Horiguchi N et al. A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells. Gut 2002 50 : 563 7.
24. Yoshizawa K, Cioca DP, Kawa S, Tanaka E, Kiyosawa K. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines. Cancer 2002 95 : 2243 51.
25. Yousef IM, Ho J, Jeejeebhoy KN. Bile acid synthesis in isolated rat hepatocytes. Can. J. Biochem. 1978 56 : 780 6.
26. Hashimoto S, Uchida K, Hirata M. Hepatic bile acid elution by albumin and bile acid content in isolated rat hepatocytes. Lipids 1982 17 : 149 54.
27. Reinehr R, Graf D, Haussinger D. Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation. Gastroenterology 2003 125 : 839 53.
28. Haussinger D, Kurz AK, Wettstein M, Graf D, Vom Dahl S, Schliess F. Involvement of integrins and Src in tauroursodeoxycholate-induced and swelling-induced choleresis. Gastroenterology 2003 124 : 1476 87.
29. Fang Y, Han SI, Mitchell C et al. Bile acids induce mitochondrial ROS, which promote activation of receptor tyrosine kinases and signaling pathways in rat hepatocytes. Hepatology 2004 40 : 961 71.
30. Rao YP, Studer EJ, Stravitz RT et al. Activation of the Raf-1/MEK/ERK cascade by bile acids occurs via the epidermal growth factor receptor in primary rat hepatocytes. Hepatology 2002 35 : 307 14.
31. Chang L, Krin M. Mammalian MAP kinase signalling cascades. Nature (Lond.) 2001 410 : 1203 13.
32. Camp HS, Tafuri SR. Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase. J. Biol. Chem. 1997 272 : 10811 16.
33. Floyd ZE, Stephens JM. Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes. J. Biol. Chem. 2002 277 : 4062 8.
34. Hauser S, Adelmant G, Sarraf P, Wright HM, Muller E, Spiegelman BM. Degradation of the peroxisome proliferators-activated receptor gamma is linked to ligand-dependent activation. J. Biol. Chem. 2000 275 : 18527 33.
35. Reginato MJ, Krakow SL, Bailey ST, Lazar MA. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor? J. Biol. Chem. 1998 273 : 1855 8.
36. Shao D, Rangwala SM, Bailey ST, Krakow SL, Reginato MJ, Lazar MA. Interdomain communication regulating ligand binding by PPAR-γ. Nature 1998 396 : 377 80.